APA

Lennard T. W., Harris A. L., Hales J., Dickinson A., Wolstencroft R., Halcrow P., Shenton B. K., McDonald M., Lawrence G. F. & Taylor R. M. (19900122). A phase I study of immunostimulation and toxicity in patients with colorectal carcinoma using the immunomodulator 3,6-bis(2-piperidinoethoxy) acridine trihydrochloride (CL 246738). : European journal of cancer & clinical oncology.

Chicago

Lennard T W, Harris A L, Hales J, Dickinson A, Wolstencroft R, Halcrow P, Shenton B K, McDonald M, Lawrence G F and Taylor R M. 19900122. A phase I study of immunostimulation and toxicity in patients with colorectal carcinoma using the immunomodulator 3,6-bis(2-piperidinoethoxy) acridine trihydrochloride (CL 246738). : European journal of cancer & clinical oncology.

Harvard

Lennard T. W., Harris A. L., Hales J., Dickinson A., Wolstencroft R., Halcrow P., Shenton B. K., McDonald M., Lawrence G. F. and Taylor R. M. (19900122). A phase I study of immunostimulation and toxicity in patients with colorectal carcinoma using the immunomodulator 3,6-bis(2-piperidinoethoxy) acridine trihydrochloride (CL 246738). : European journal of cancer & clinical oncology.

MLA

Lennard T W, Harris A L, Hales J, Dickinson A, Wolstencroft R, Halcrow P, Shenton B K, McDonald M, Lawrence G F and Taylor R M. A phase I study of immunostimulation and toxicity in patients with colorectal carcinoma using the immunomodulator 3,6-bis(2-piperidinoethoxy) acridine trihydrochloride (CL 246738). : European journal of cancer & clinical oncology. 19900122.